beclometasone/formotero; Single inhaler Maintenance And Reliever Therapy (SMART)

^[1]^[2]

Indications

↑ ^1.0 ^1.1 ^1.2 Papi A et al Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial Lancet Respir Med. March 2013, 1(1):23-31 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24321801 <Internet> http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)70012-2/abstract
Patel M et al Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med. March 2013, 1(1):32-42 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24321802 <Internet> http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)70007-9/abstract
↑ ^2.0 ^2.1 Riemersma RA, Postma D, van der Molen T. Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control. Prim Care Respir J. 2012 Mar;21(1):50-6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22015542